Pfizer CEO discusses AI's role in drug discovery and healthcare innovation

Pfizer CEO Albert Bourla discussed AI's transformative potential in healthcare, covering drug discovery and clinical research, and emphasized the need for business-government collaboration to keep pace with technological advances. The discussion is forward-looking with no specific announcements or data, so its immediate impact is limited.